Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence

Margreet C. M. Vissers; Andrew B. Das

doi:10.3389/fphys.2018.00809

journal article Open Access Jul 03, 2018

Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence

Margreet C. M. Vissers Andrew B. Das

Frontiers in Physiology Vol. 9 · Frontiers Media SA

View at Publisher Save 10.3389/fphys.2018.00809

Topics

No keywords indexed for this article. Browse by subject →

References

188

[1]

Agathocleous "Ascorbate regulates haematopoietic stem cell function and leukaemogenesis." Nature (2017) 10.1038/nature23876

[2]

Aguilera "Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer." Oncotarget (2016) 10.18632/oncotarget.10087

[3]

An "Vitamin C increases the apoptosis via up-regulation p53 during cisplatin treatment in human colon cancer cells." BMB Rep. (2011) 10.5483/bmbrep.2011.44.3.211

[4]

Anthony "Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance." Br. J. Cancer (1982) 10.1038/bjc.1982.211

[5]

Badid "Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer." Pathol. Oncol. Res. (2010) 10.1007/s12253-009-9199-0

[6]

Banhegyi "Ascorbate metabolism and its regulation in animals." Free Radic. Biol. Med. (1997) 10.1016/s0891-5849(97)00062-2

[7]

Baylin "A decade of exploring the cancer epigenome - biological and translational implications." Nat. Rev. Cancer (2011) 10.1038/nrc3130

[8]

Baylin "Epigenetic determinants of cancer." Cold Spring Harb. Perspect. Biol. (2016) 10.1101/cshperspect.a019505

[9]

Belin "Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression." PLoS One (2009) 10.1371/journal.pone.0004409

[10]

Berman "Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains." Nat. Genet. (2011) 10.1038/ng.969

[11]

Bishop "Signaling hypoxia by hypoxia-inducible factor protein hydroxylases: a historical overview and future perspectives." Hypoxia (2014)

[12]

Bonham "Early ascorbic acid depletion is related to the severity of acute pancreatitis." Br. J. Surg. (1999) 10.1046/j.1365-2168.1999.01182.x

[13]

Buettner "Activation of oxygen by metal complexes and its relevance to autoxidative processes in living systems." Bioelectrochem. Bioenerg. (1987) 10.1016/0302-4598(87)85005-5

[14]

Buettner "In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metals." J. Biochem. Biophys. Methods (1988) 10.1016/0165-022x(88)90100-5

[15]

Buettner "The catalytic activity of iron in synovial fluid as monitored by the ascorbate free radical." Free Radic. Biol. Med. (1990) 10.1016/0891-5849(90)90144-8

[16]

Busque "Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis." Nat. Genet. (2012) 10.1038/ng.2413

[17]

Camarena "The epigenetic role of vitamin C in health and disease." Cell. Mol. Life Sci. (2016) 10.1007/s00018-016-2145-x

[18]

Cameron "Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases." Oncology (1973) 10.1159/000224733

[19]

Cameron "Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer." Proc. Natl. Acad. Sci. U.S.A. (1976) 10.1073/pnas.73.10.3685

[20]

Cameron "Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer." Proc. Natl. Acad. Sci. U.S.A. (1978) 10.1073/pnas.75.9.4538

[21]

Campbell "Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo(-/-) mice." Cancer Med. (2015) 10.1002/cam4.349

[22]

Campbell "Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo-/- mice." Hypoxia

[23]

Campbell "Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice." Free Radic. Biol. Med. 10.1016/j.freeradbiomed.2016.08.027

[24]

Cao "Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications." BMC Cancer (2009) 10.1186/1471-2407-9-432

[25]

Carosio "Sodium ascorbate induces apoptosis in neuroblastoma cell lines by interfering with iron uptake." Mol. Cancer (2007) 10.1186/1476-4598-6-55

[26]

Carr "Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans." Am. J. Clin. Nutr. (1999) 10.1093/ajcn/69.6.1086

[27]

Castro "Radiosensitisation by pharmacological ascorbate in glioblastoma multiforme cells, human glial cells, and HUVECs depends on their antioxidant and DNA repair capabilities and is not cancer specific." Free Radic. Biol. Med. (2014) 10.1016/j.freeradbiomed.2014.06.022

[28]

Cha "Ascorbate depletion increases growth and metastasis of melanoma cells in vitamin C deficient mice." Exp. Oncol. (2011)

[29]

Cha "Ascorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C-deficient mice." Int. J. Oncol. (2013) 10.3892/ijo.2012.1712

[30]

Chatterjee "Synthesis and some major functions of vitamin C in animals." Ann. N. Y. Acad. Sci. (1975) 10.1111/j.1749-6632.1975.tb29266.x

[31]

Chen "Anti-cancer effect of pharmacologic ascorbate and its interaction with supplementary parenteral glutathione in preclinical cancer models." Free Radic. Biol. Med. (2011) 10.1016/j.freeradbiomed.2011.05.031

[32]

Chen "Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy." Anti Cancer Drugs (2012) 10.1097/cad.0b013e32834fd01f

[33]

Chen "Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues." Proc. Natl. Acad. Sci. U.S.A. (2005) 10.1073/pnas.0506390102

[34]

Chen "Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo." Proc. Natl. Acad. Sci. U.S.A. (2007) 10.1073/pnas.0702854104

[35]

Chen "Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice." Proc. Natl. Acad. Sci. U.S.A. (2008) 10.1073/pnas.0804226105

[36]

Cieslak "Treatment of pancreatic cancer with pharmacological ascorbate." Curr. Pharm. Biotechnol. (2015) 10.2174/138920101609150715135921

[37]

Cieslak "Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer." Free Radic. Biol. Med. (2015) 10.1016/j.freeradbiomed.2015.02.018

[38]

Cimmino "Restoration of TET2 function blocks aberrant self-renewal and leukemia progression." Cell (2017) 10.1016/j.cell.2017.07.032

[39]

Cimmino "Vitamin C in stem cell reprogramming and cancer." Trends Cell Biol. (2018) 10.1016/j.tcb.2018.04.001

[40]

Clement "The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide." Antioxid. Redox Signal. (2001) 10.1089/152308601750100687

[41]

Corpe "Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8." J. Biol. Chem. (2005) 10.1074/jbc.m112.436790

[42]

Dachs "Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation." Eur. J. Cancer (2000) 10.1016/s0959-8049(00)00159-3

[43]

De Francesco "Vitamin C and Doxycycline: a synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs)." Oncotarget (2015) 10.18632/oncotarget.18428

[44]

Deb "Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer." Mod. Pathol. (2014) 10.1038/modpathol.2013.231

[45]

Dhariwal "Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum." Am. J. Clin. Nutr. (1991) 10.1093/ajcn/54.4.712

[46]

Doskey "Tumor cells have decreased ability to metabolize H2O2: implications for pharmacological ascorbate in cancer therapy." Redox Biol. (2010) 10.1016/j.redox.2016.10.010

[47]

Drisko "The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer." J. Am. Coll. Nutr. (2003) 10.1080/07315724.2003.10719284

[48]

Du "Ascorbic acid: chemistry, biology and the treatment of cancer." Biochim. Biophys. Acta (2012) 10.1016/j.bbcan.2012.06.003

[49]

Du "Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer." Clin. Cancer Res. (2010) 10.1158/1078-0432.ccr-09-1713

[50]

Ehrlich "DNA hypomethylation and hemimethylation in cancer." Adv. Exp. Med. Biol. (2013) 10.1007/978-1-4419-9967-2_2

Showing 50 of 188 references

Cited By

149

Interactions between Dietary Antioxidants, Dietary Fiber and the Gut Microbiome: Their Putative Role in Inflammation and Cancer

Camelia Munteanu, Betty Schwartz · 2024

International Journal of Molecular...

Glioblastoma: Current Status, Emerging Targets, and Recent Advances

Amandeep Thakur, Chetna Faujdar · 2022

Journal of Medicinal Chemistry

High-Dose Vitamin C for Cancer Therapy

Ali Mussa, Ros Akmal Mohd Idris · 2022

Pharmaceuticals

Mechanisms that regulate the activities of TET proteins

Kanak Joshi, Shanhui Liu · 2022

Experientia

Vitamin C Cytotoxicity and Its Effects in Redox Homeostasis and Energetic Metabolism in Papillary Thyroid Carcinoma Cell Lines

Laura Tronci, Gabriele Serreli · 2021

Antioxidants

Solid lipid nanoparticles for hydrophilic drugs

Yashika Mirchandani, Vandana B. Patravale · 2021

Journal of Controlled Release

Metrics

149

Citations

188

References

Details

Published: Jul 03, 2018
Vol/Issue: 9
License: View

Authors

M

Margreet C. M. Vissers

A

Andrew B. Das

Funding

University of Otago

Cite This Article

Margreet C. M. Vissers, Andrew B. Das (2018). Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence. Frontiers in Physiology, 9. https://doi.org/10.3389/fphys.2018.00809

Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence

You May Also Like